by Sophie Will Source: Life Science Leader By Leeann Ali Startups and small companies are crucial to the development of breakthrough drugs and therapies, but with limited capital it is essential that they move quickly and efficiently during clinical trials to maximize the potential for successful outcomes. Designing and executing a clinical trial…
CityPoint will serve as new headquarters for growing company in biotech space. WALTHAM, MA. – Nov. 29, 2021 – BioBridges, a clinical development professional services company for pharmaceutical, biotechnology and medical device companies, today announced it is relocating to 230 CityPoint to accommodate its rapid growth and further leverage the…
BioBridges has been engaged by an established specialty pharmaceutical company, located in California, to provide biostatistical expertise in writing statistical protocol for phase 1b design and support clinical programs.
BioBridges has been engaged by an established, Boston-based, biopharmaceutical company to provide data management expertise to oversee CROs, oversee vendor management, review data, and perform QC for inaccuracies.
BioBridges has been engaged by an established, Boston-based, biopharmaceutical company to provide medical writing expertise to edit clinical documents, clinical publications, protocols, and perform data QC against source documents.
BioBridges has been engaged by an established biopharmaceutical company, located near Boston, to provide medical and clinical expertise to support a clinical team by ramping up sites, oversee, and direct efforts of site initiation, be responsible for study conduct, and handle medical queries from sites.
BioBridges has been engaged by an emerging biopharmaceutical company, located near the San Francisco Bay area, to provide clinical program management expertise to support the implementation of clinical project plans and provide oversight of clinical operations and development activities.
BioBridges has been engaged by an emerging biopharmaceutical company, located near Boston, to provide clinical regulatory writing expertise to directly author content to be utilized in various regulatory documents and QC existing content that needs development.
BioBridges has been engaged by a Washington-based, biotechnology company, to provide quality validation expertise in 21 CFR Part 11 and support validation activities for an SAS server.
BioBridges has been engaged by an emerging, Seattle-based, biotechnology company to provide clinical supply chain expertise to lead and ensure that all supplies are controlled and distributed in accordance with GMP, GCP, and GDP regulations, work with the vendor to ensure that clinical drug supply is available for global clinical…